Treatment of myasthenia gravis patients with calcineurin inhibitors in Japan: A retrospective analysis of outcomes

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-1961|6|2|195-200

ISSN： 1759-1961

Source： CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol.6, Iss.2, 2015-05, pp. : 195-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How should we use calcineurin inhibitors in myasthenia gravis?

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 2, 2015-05 ,pp. : 118-119

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating memory B cells are reduced in patients with late‐onset myasthenia gravis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 3, 2015-08 ,pp. : 322-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

What should we target? The beginning of a new era in the diagnosis and treatment of myasthenia gravis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Japanese clinical guidelines for myasthenia gravis: Putting into practice

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 21-31

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life measures for myasthenia gravis and evaluation of non‐motor symptoms

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 1, 2015-02 ,pp. : 32-39

John Wiley & Sons Inc

Access to resources Recommend Favorite